Author

Albert G. Wendt

Observed names: A. Wendt, Albert Guy Wendt, Albert Wendt

Institutions: St. Joseph's Hospital and Medical Center, Dignity Health

Observed institutions: St. Joseph's Hospital and Medical Center, Dignity Health, Jena University Hospital, University of Arizona Cancer Center

OpenAlex ID: A5004051297

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

2024 · Mariana Chavez-MacGregor, Jieling Miao, et al. · Journal of Clinical Oncology · 17

Treatment of Early Breast Cancer With Adriamycin-Cyclophosphamide With or Without Radiation Therapy: Initial Results of a Brief and Effective Adjuvant Program

1979 · S. E. Salmon, A. Wendt, et al. · Recent results in cancer research/Recent Results in Cancer Research · 7

Abstract GS1-07: Results from a phase III randomized, placebo-controlled clinical trial evaluating adjuvant endocrine therapy +/- 1 year of everolimus in patients with high-risk hormone receptor-positive, HER2-negative breast cancer: SWOG S1207

2023 · Marianna Chavez, Jieling Miao, et al. · Cancer Research · 4

Performance Evaluation Criteria Development for Electrical Craftsmen

1997 · Albert G. Wendt · Construction Congress V: Managing Engineered Construction in Expanding Global Markets · 1

Late line treatment in hormone receptor positive, her 2 neu positive metastatic breast cancer with fulvestrant, abemaciclib, and trastuzumab, including prolonged CNS control.

2026 · Albert Guy Wendt · Journal of Clinical Oncology

Abstract P5-04-23: Genomic Investigation of Angioma in Mammary Cancer

2025 · Rachel Geiser, Lorinda Baker, et al. · Clinical Cancer Research

Immunhistochemical analysis of RUNX3 expression in breast cancer and RUNX3 characterization in TNBC cell lines

2024 · A. Wendt, M. Türe, et al. · Geburtshilfe und Frauenheilkunde

Abstract PO1-09-06: Patient Barriers to Genetic Counseling

2024 · Karen Dirrigl, Lora Hebert, et al. · Cancer Research

Interval Exercise Preconditioning And Cardiac Function Following Dose-dense Doxorubicin Therapy In Breast Cancer - Preliminary Results

2021 · Nathan Weeldreyer, Albert G. Wendt, et al. · Medicine & Science in Sports & Exercise

Works count: 9

Citation count: 29

H-index: 3

I10-index: 1